TauC3 Biologics Limited Announces the Appointments of Industry Leaders Andrew Heath MD, PhD and Shafique Virani, MD as Non-...
LONDON, Jan. 10, 2020 (GLOBE NEWSWIRE) -- TauC3 Biologics Limited, a newly established privately held British biopharmaceutical company developing an innovative immunotherapy with the demonstrated potential to prevent the spread of tau pathology in the …